Akt signaling has been introduced as one of the main mechanisms involved in cell survival59,60 and it is commonly dysregulated in PD patients.61 However, treatment with this cur-nanoformulation in protective doses up-regulates the p-Akt/t-Akt signaling pathway. The gene discussed is AKT1; the disease is Parkinson disease.